| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC3341 |
| Trial ID | NCT05739227 |
| Disease | B-Cell Lymphoma | Chronic Lymphocytic Leukemia | Acute Lymphoblastic Leukemia |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-NK cell |
| Treatment | CD19 CAR-NK cells |
| Phase | Early_Phase1 |
| Recruitment status | Recruiting |
| Title | Safety and Efficacy of Allogenic CD19-CAR-NK Cells in Treatmenting r/r B-cell Hematologic Malignancies |
| Year | 2023 |
| Country | China |
| Company sponsor | Xuzhou Medical University |
| Other ID(s) | XYFY2022-KL252-01 |
| Cohort 1 | |||||||||||||
|
|||||||||||||